Exelixis, Inc. cash flow to debt ratio of 511.02% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

Exelixis, Inc.'s free cash flow has increased 33.22% from $633.79M last year to $844.34M, signaling increasing performance

Exelixis, Inc.'s debt to equity ratio is 0.09, which means that the company's assets are healthy financed, signaling financial stability.

Exelixis, Inc.'s debt has increased relative to shareholder equity from 0.09 last year to 0.09 today, signaling weakened financials

Exelixis, Inc. has a net cash position, so leverage is healthy.

Exelixis, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Exelixis, Inc.'s profit margin has increased (46.99%) in the last year from 24.04% to 35.33%, signaling increasing performance

Exelixis, Inc.'s short-term assets of $1.44B exceed its short-term liabilities of $405.64M

Exelixis, Inc.'s return on assets of 34.50% is higher than the 5.00% threshold, indicating efficient asset utilization

Exelixis, Inc.'s return on equity of 42.49%, is higher than 15.00%, indicating good performance

Exelixis, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Exelixis, Inc. had positive net income in 5 out of 5 years, indicating stable and consistent earnings

Exelixis, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Exelixis, Inc. has a free cash flow yield of 6.34%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Exelixis, Inc.'s yearly earnings has increased 50.13% since last year from $521.27M to $782.57M, signaling increasing performance

Exelixis, Inc.'s yearly revenue has increased 6.98% since last year from $2.17B to $2.32B, signaling increasing performance

ROIC 37.87% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Exelixis, Inc.'s 3-year revenue CAGR of 12.93% is positive, indicating growing revenue over the past 3 years

Exelixis, Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance

Exelixis, Inc. had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

Exelixis, Inc. is undervalued relative to its fair value price of 58.90 based on Discounted Cash Flow model

Exelixis, Inc. has an earnings yield of 6.48%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Exelixis, Inc. is overvalued relative to its fair value price of 26.04 based on EBITDA multiple model

Exelixis, Inc. has an EV/EBITDA ratio of 13.48x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Exelixis, Inc. is overvalued relative to its fair value price of 29.88 based on Earnings Fair Value model

Exelixis, Inc. has a PEG-ratio under 1 which is considered undervalued

Exelixis, Inc. has a price-to-book ratio of 7.20x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Exelixis, Inc. has a price-to-sales ratio of 5.45x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue